These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 34377010)

  • 1. Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma.
    Dai T; Li J; Lu X; Ye L; Yu H; Zhang L; Deng M; Zhu S; Liu W; Wang G; Yang Y
    Pharmgenomics Pers Med; 2021; 14():927-945. PubMed ID: 34377010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Metabolism-Related Signature as a Candidate Prognostic Biomarker for Hepatocellular Carcinoma.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    J Hepatocell Carcinoma; 2021; 8():119-132. PubMed ID: 33758763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
    Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
    Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of ferroptosis-related genes for clinical and biological significance in hepatocellular carcinoma.
    Wu Q; Tan Z; Xiong Y; Gu C; Zhou J; Yang H; Zhou J
    Discov Oncol; 2023 May; 14(1):69. PubMed ID: 37198416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
    Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
    Front Genet; 2022; 13():907331. PubMed ID: 35938001
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma.
    Wen K; Yan Y; Shi J; Hu L; Wang W; Liao H; Li H; Zhu Y; Mao K; Xiao Z
    Front Mol Biosci; 2021; 8():809672. PubMed ID: 34977159
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma.
    Zheng C; Peng Y; Wang H; Wang Y; Liu L; Zhao Q
    Pharmgenomics Pers Med; 2023; 16():39-58. PubMed ID: 36726530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Ferroptosis-Related Signature Model Including mRNAs and lncRNAs for Predicting Prognosis and Immune Activity in Hepatocellular Carcinoma.
    Chen ZA; Tian H; Yao DM; Zhang Y; Feng ZJ; Yang CJ
    Front Oncol; 2021; 11():738477. PubMed ID: 34568075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of an eight-gene signature based predictive model to evaluate the prognosis of hepatocellular carcinoma patients: a bioinformatic study.
    Zhang J; Fu X; Zhang N; Wang W; Liu H; Jia Y; Nie Y
    Ann Transl Med; 2022 May; 10(9):524. PubMed ID: 35928748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
    Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
    Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma.
    Wang L; Ge X; Zhang Z; Ye Y; Zhou Z; Li M; Yan H; Wu L; Bai Q; Li J; Zhu J; Wang Y
    Front Genet; 2021; 12():682082. PubMed ID: 34745200
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma.
    Dai T; Ye L; Yu H; Li K; Li J; Liu R; Lu X; Deng M; Li R; Liu W; Yang Y; Wang G
    J Hepatocell Carcinoma; 2021; 8():997-1021. PubMed ID: 34513744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes.
    Wan S; Lei Y; Li M; Wu B
    Hepatol Int; 2022 Feb; 16(1):112-124. PubMed ID: 34449009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and validation of a ferroptosis-related prognostic signature for hepatocellular carcinoma.
    He Y; Wu Y; Song M; Yang Y; Yu Y; Xu S
    Front Oncol; 2023; 13():1149370. PubMed ID: 37143953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma.
    Liu JF; Huang L; Zhou XP; Li CR; Liu MF; Liang YH; Yu QH; Wu JR
    Transl Cancer Res; 2024 Feb; 13(2):496-514. PubMed ID: 38482398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
    Li C; Cui X; Li Y; Guo D; He S
    Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role and Potential Mechanisms of N6-methyladenosine-related Long Noncoding RNAs in Hepatocellular Carcinoma.
    Dai T; Li J; Ye L; Yu H; Deng M; Liu W; Li H; Yang Y; Wang G
    J Clin Transl Hepatol; 2022 Apr; 10(2):308-320. PubMed ID: 35528973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic risk model, tumor immune environment modulation, and drug prediction of ferroptosis and amino acid metabolism-related genes in hepatocellular carcinoma.
    Ji L; Zhang Q; Cao Y; Liu L
    Hum Cell; 2023 May; 36(3):1173-1189. PubMed ID: 36892792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Analysis of Immunity- and Ferroptosis-Related Biomarker Signatures to Improve the Prognosis Prediction of Hepatocellular Carcinoma.
    Du X; Zhang Y
    Front Genet; 2020; 11():614888. PubMed ID: 33391356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.